• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者脑脊液中特征性的神经节苷脂抗体模式。
J Neurol Neurosurg Psychiatry. 1993 Apr;56(4):361-4. doi: 10.1136/jnnp.56.4.361.
2
CSF and serum ganglioside antibody patterns in MS.多发性硬化症患者脑脊液和血清中的神经节苷脂抗体模式。
Acta Neurol Scand. 1992 Nov;86(5):485-9. doi: 10.1111/j.1600-0404.1992.tb05129.x.
3
Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis.
Ann Neurol. 1989 Jan;25(1):98-102. doi: 10.1002/ana.410250118.
4
Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a.多发性硬化症与B细胞对神经节苷脂GD1a的反应增强有关。
Mult Scler. 1999 Dec;5(6):379-88. doi: 10.1177/135245859900500i603.
5
Anti-ganglioside antibodies in amyotrophic lateral sclerosis revisited.肌萎缩侧索硬化症中抗神经节苷脂抗体的再探讨。
PLoS One. 2015 Apr 14;10(4):e0125339. doi: 10.1371/journal.pone.0125339. eCollection 2015.
6
Association of polyclonal anti-GM1 IgM and anti-neurofilament antibodies with CSF oligoclonal bands in a young with amyotrophic lateral sclerosis.
Acta Neurol Scand. 1995 Nov;92(5):387-93. doi: 10.1111/j.1600-0404.1995.tb00152.x.
7
Cerebrospinal fluid antibodies directed against neuron-associated gangliosides in HIV-1 infection.HIV-1感染中针对神经元相关神经节苷脂的脑脊液抗体。
Infection. 2000 May-Jun;28(3):143-8. doi: 10.1007/s150100050067.
8
Novel lacto-ganglio type gangliosides with GM2-epitope in bovine brain which react with IgM from a patient of the amyotrophic lateral sclerosis-like disorder.牛脑中具有GM2表位的新型乳糖神经节苷脂型神经节苷脂,与肌萎缩侧索硬化样疾病患者的IgM发生反应。
J Biol Chem. 1993 Oct 5;268(28):21028-34.
9
Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients.肌萎缩侧索硬化症(ALS)患者血清和脑脊液中的抗神经抗体。
Acta Neurol Scand. 1999 Oct;100(4):238-43. doi: 10.1111/j.1600-0404.1999.tb00387.x.
10
[Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].[通过免疫斑点印迹法检测抗神经节苷脂自身抗体:在外周神经病变中的临床意义]
Ann Biol Clin (Paris). 1999 Sep-Oct;57(5):579-88.

引用本文的文献

1
Gangliosides as Therapeutic Targets for Neurodegenerative Diseases.神经节苷脂作为神经退行性疾病的治疗靶点
J Lipids. 2024 Apr 8;2024:4530255. doi: 10.1155/2024/4530255. eCollection 2024.
2
Ganglioside GM1 and the Central Nervous System.神经节苷脂 GM1 与中枢神经系统。
Int J Mol Sci. 2023 May 31;24(11):9558. doi: 10.3390/ijms24119558.
3
Involvement of Lipids in the Pathogenesis of Amyotrophic Lateral Sclerosis.脂质在肌萎缩侧索硬化症发病机制中的作用
Life (Basel). 2023 Feb 12;13(2):510. doi: 10.3390/life13020510.
4
Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine.解析 ALS 中的脂质失调:从机制到转化医学。
Transl Neurodegener. 2022 Nov 7;11(1):48. doi: 10.1186/s40035-022-00322-0.
5
Blood-brain barrier dysfunction and myelin basic protein in survival of amyotrophic lateral sclerosis with or without frontotemporal dementia.血脑屏障功能障碍与髓鞘碱性蛋白在伴或不伴额颞叶痴呆的肌萎缩侧索硬化症存活中的作用
Neurol Sci. 2022 May;43(5):3201-3210. doi: 10.1007/s10072-021-05731-z. Epub 2021 Nov 26.
6
Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications.大脑中的神经节苷脂:生理学、病理生理学及治疗应用
Front Neurosci. 2020 Oct 6;14:572965. doi: 10.3389/fnins.2020.572965. eCollection 2020.
7
Disrupted glycosylation of lipids and proteins is a cause of neurodegeneration.脂质和蛋白质糖基化的紊乱是神经退行性变的一个原因。
Brain. 2020 May 1;143(5):1332-1340. doi: 10.1093/brain/awz358.
8
Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis.糖鞘脂是肌萎缩侧索硬化症疾病发病机制的调节因子。
Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):8100-5. doi: 10.1073/pnas.1508767112. Epub 2015 Jun 8.
9
GT1b-induced neurotoxicity is mediated by the Akt/GSK-3/tau signaling pathway but not caspase-3 in mesencephalic dopaminergic neurons.GT1b 诱导的神经毒性是通过 Akt/GSK-3/tau 信号通路介导的,但在中脑多巴胺能神经元中不通过 caspase-3。
BMC Neurosci. 2010 Jun 12;11:74. doi: 10.1186/1471-2202-11-74.
10
Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants.自身抗体在吉兰-巴雷综合征及其变异型中的临床应用
Clin Rev Allergy Immunol. 1998 Fall;16(3):265-73. doi: 10.1007/BF02737636.

本文引用的文献

1
Gangliosides of human spinal cord: aberrant composition of cords from patients with amyotrophic lateral sclerosis.人类脊髓神经节苷脂:肌萎缩侧索硬化症患者脊髓的异常组成
J Neurosci Res. 1984;12(2-3):213-20. doi: 10.1002/jnr.490120209.
2
Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients.
J Neuroimmunol. 1984 Feb;6(1):51-7. doi: 10.1016/0165-5728(84)90042-0.
3
Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune responses to viral and CNS antigens.肌萎缩侧索硬化症患者的免疫特征及其对病毒和中枢神经系统抗原的细胞介导免疫反应。
Clin Exp Immunol. 1982 Apr;48(1):137-46.
4
Ganglioside patterns in amyotrophic lateral sclerosis brain regions.肌萎缩侧索硬化症脑区中的神经节苷脂模式。
Ann Neurol. 1985 Jul;18(1):60-7. doi: 10.1002/ana.410180111.
5
Motor neuron disease and plasma cell dyscrasia.
Neurology. 1986 Nov;36(11):1429-36. doi: 10.1212/wnl.36.11.1429.
6
Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations.
Arch Neurol. 1986 Mar;43(3):234-8. doi: 10.1001/archneur.1986.00520030026007.
7
Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中针对GM1神经节苷脂的血清抗体。
Neurology. 1988 Sep;38(9):1457-61. doi: 10.1212/wnl.38.9.1457.
8
Amyotrophic lateral sclerosis. Recent advances in pathogenesis and therapeutic trials.肌萎缩侧索硬化症。发病机制与治疗试验的最新进展。
Arch Neurol. 1988 Feb;45(2):189-202. doi: 10.1001/archneur.1988.00520260077025.
9
Antineural antibodies in the serum of patients with amyotrophic lateral sclerosis.
Neurology. 1987 Jan;37(1):152-5. doi: 10.1212/wnl.37.1.152.
10
Amyotrophic lateral sclerosis: an unconventional autoimmune disease?
Ann Neurol. 1989 Aug;26(2):269-74. doi: 10.1002/ana.410260214.

肌萎缩侧索硬化症患者脑脊液中特征性的神经节苷脂抗体模式。

A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.

作者信息

Stevens A, Weller M, Wiethölter H

机构信息

Department of Neurology, University of Tübingen, Germany.

出版信息

J Neurol Neurosurg Psychiatry. 1993 Apr;56(4):361-4. doi: 10.1136/jnnp.56.4.361.

DOI:10.1136/jnnp.56.4.361
PMID:7683329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1014951/
Abstract

Paired cerebrospinal fluid and serum samples of patients with amyotrophic lateral sclerosis (n = 35) revealed no consistent abnormalities of CSF cell count, CSF albumin, CSF IgG, CSF IgM, IgG or IgM index, or oligoclonal immunoglobulin band formation in the CSF. Determination of IgG and IgM CSF and serum antibodies to gangliosides GM1, GM2, GM3, AGM1, GD1a, GD1b, and GT1b showed a characteristic pattern which allowed the differentiation of amyotrophic lateral sclerosis from controls and from patients with other neurological disorders including multiple sclerosis. Specifically, patients with the disease had elevated CSF IgM antibodies to all gangliosides except AGM1. The lack of correlation between the CSF findings and corresponding serum antibodies suggests a chronic, compartmental, intrathecal immune response of low activity in amyotrophic lateral sclerosis. Whether this immune response is primary and of pathogenetic significance, or an epiphenomenon of neuronal degeneration, remains to be investigated.

摘要

对35例肌萎缩侧索硬化症患者的配对脑脊液和血清样本进行检测,结果显示脑脊液细胞计数、脑脊液白蛋白、脑脊液IgG、脑脊液IgM、IgG或IgM指数,以及脑脊液中寡克隆免疫球蛋白带形成均无一致异常。对脑脊液和血清中针对神经节苷脂GM1、GM2、GM3、AGM1、GD1a、GD1b和GT1b的IgG和IgM抗体进行检测,结果呈现出一种特征性模式,可用于区分肌萎缩侧索硬化症患者与对照组以及其他神经系统疾病患者(包括多发性硬化症患者)。具体而言,该病患者除针对AGM1外,针对所有神经节苷脂的脑脊液IgM抗体均升高。脑脊液检测结果与相应血清抗体之间缺乏相关性,提示肌萎缩侧索硬化症存在慢性、局部、鞘内低活性免疫反应。这种免疫反应是原发性的且具有致病意义,还是神经元变性的一种附带现象,仍有待研究。